Virtus Health (VRT) Stock Price, News & Analysis

Company Overview

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore. The company operates through two segments, Healthcare Services Australia and Healthcare Services International. It provides fertility services, medical day procedure services, and medical diagnostics and pathology services. It also offers in-vitro fertilization (IVF) services. In addition, the company offers medical day procedure services, such as gastroenterologists, colorectal surgeons, plastic surgeons, urologists, gynecologists, ophthalmologists, dental surgeons, hand surgeons, and other surgeons. As of August 23, 2021, it operated through a network of 128 fertility specialists supported by approximately 1300 professional staff. Virtus Health Limited was founded in 2008 and is headquartered in Greenwich, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 339,634 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 2.96%
• Price Target: N/A
• Consensus Rating: N/A

VRT Stock Analysis - Frequently Asked Questions

How were Virtus Health's earnings last quarter?

Virtus Health Limited (ASX:VRT) released its earnings results on Tuesday, February, 19th. The company reported $0.18 earnings per share (EPS) for the quarter.

What other stocks do shareholders of Virtus Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus Health investors own include Revvity (PKI), Gray Media (GTN), (NESCQ) (NESCQ), Teradyne (TER), AbbVie (ABBV), Aphria (APHA) and AquaBounty Technologies (AQB).

Company Calendar

• Last Earnings: 2/19/2019
• Today: 7/02/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Care
• Sub-Industry: Electronic Equipment
• Current Symbol: ASX:VRT
• CIK: N/A
• Web: virtushealth.com.au
• Phone: +61-2-94251722
• Fax: N/A
• Employees: 27,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 11.91
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 53.60
• Current Ratio: 0.54
• Quick Ratio: 0.43

Sales & Book Value

• Annual Sales: A$335.40 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 20.38
• Book Value: A$3.96 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 87,113,800
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A